Clinical Trial Details
| Trial ID: | L2750 |
| Source ID: | NCT04553380 |
| Associated Drug: | Basic Insulin |
| Title: | Study on the Feasibility of Community Doctors Guided by Specialists to Use Basic Insulin |
| Acronym: | |
| Status: | UNKNOWN |
| Study Results: | NO |
| Results: | |
| Conditions: | Type 2 Diabetes |
| Interventions: | DRUG: basic insulin |
| Outcome Measures: | Primary: Time to achieve target FBG, Treatment days when FBG reached the standard (≤ 7.0mmol/L) after treatment with basal insulin., From the beginning of intervention to fasting blood glucose ≤ 7.0mmol/L，assessed up to 3 months.|Decrease of HbA1c, The change of HbA1c before and after treatment with basal insulin., At the end of 3 months of follow-up.|Incidence of hypoglycemia, The proportion of the occurrence of hypoglycemia to the number of total blood glucose monitoring., At the end of 3 months of follow-up. | Secondary: Daily doses of insulin at the study end point., The daily doses of insulin at the study end point., At the end of 3 months of follow-up. |
| Sponsor/Collaborators: | Sponsor: Shenzhen Second People's Hospital |
| Gender: | ALL |
| Age: | ADULT, OLDER_ADULT |
| Phases: | |
| Enrollment: | 150 |
| Study Type: | INTERVENTIONAL |
| Study Designs: | Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT |
| Start Date: | 2020-12-01 |
| Completion Date: | 2022-03-31 |
| Results First Posted: | |
| Last Update Posted: | 2020-09-17 |
| Locations: | |
| URL: | https://clinicaltrials.gov/show/NCT04553380 |
| Drug ID | Drug Name | Type | DrugBank ID | Targets | Category | Latest Progress |
|---|